SOURCE: Patheon


April 07, 2015 14:00 ET

Patheon to Participate in Industry Panels and Feature Patheon OneSource™ at INTERPHEX

DURHAM, NC--(Marketwired - April 07, 2015) - Patheon, a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma industries, will showcase its broad set of development and manufacturing services, and the company's integrated offering. Company leaders will offer industry insights during key panel discussions at INTERPHEX in New York City from Tuesday, April 21 to Thursday, April 23.

Franco Negron, senior vice president of drug product services in North America for Patheon, will participate in the Executive Perspectives panel, moderated by Jim Miller, founder and president of PharmSource Information Services, Inc., Wednesday, April 22 at 1:15 p.m., to discuss industry trends and consolidation, relationships and strategic partnerships with large and small pharma companies, as well as the future of the industry.

Andrew McNicoll, vice president of quality systems and compliance for Patheon, will participate in a panel focused on Quality Agreements, Wednesday, April 22 at 2:15 p.m. The panel will cover approaches and best practices, and highlight differences in how quality agreements are employed to ensure regulatory compliance when working with clients.

While at INTERPHEX, Patheon will showcase Patheon OneSource™, the industry-leading solution that provides a simplified and customized offering, including both drug substance and drug production services to help clients get to market faster and cost effectively.

Executives, technical and scientific experts from Patheon will be attending INTERPHEX and will be available to discuss the company's full suite of services and capabilities at booth #1424. To schedule a meeting in advance, please visit, and for press inquiries, please email

About Patheon
Patheon, a business unit of DPx Holdings B.V., delivers a combination of unrivaled quality, reliability and compliance, with a reputation for scientific and technical excellence to customers in the pharmaceutical and biopharma sector. A leading global provider with more than 8,000 employees worldwide, Patheon has a comprehensive set of solutions to help customers of all sizes satisfy complex development and manufacturing needs at any stage of the pharmaceutical development cycle. For more information, visit

Contact Information